MicroRNAs in clear cell renal cell carcinoma: biological functions and applications

Gianluca Aguiari

Abstract


MicroRNAs (miRs) are small noncoding RNAs that govern many biological processes. They frequently acquire a gain or a loss of function in cancer and hence play a causative role in the development and progression of neoplasms. They could be used as biomarkers to improve our knowledge on diagnosis, prognosis and drug resistance, and to attempt therapeutic approaches in several types of cancer including clear cell renal cell carcinoma (ccRCC). ccRCC is the most predominant subtype of RCC that accounts for about 90% of all renal cancers. Since ccRCC is generally asymptomatic until very late, it is difficult to diagnose early. Moreover, in the absence of preventive treatments for metastatic ccRCC after surgical resection of the primary cancer, predictive prognostic biomarkers are needed in order to achieve appropriate therapies. Herein the role of miRs in the biology of ccRCC and the potential applications of these molecules are discussed. Moreover, future applications in the diagnostic and prognostic field, as well as their impact on drug response and therapeutic targets are also explored. Their use in clinical practice as molecular biomarkers alone, or in combination with other biological markers, could accelerate progress help design personalized therapies, limit side effects, and improve quality of life of ccRCC patients. 


Keywords


MicroRNA, renal cell carcinoma; kidney cancer, VHL

Full Text:

HTML PDF


DOI: http://dx.doi.org/10.15586/jkcvhl.2015.40

Article Metrics

Metrics Loading ...




Copyright (c) 2015 Gianluca Aguiari

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.